BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33548230)

  • 1. Structural and functional analysis of Ccr1l1, a Rodentia-restricted eosinophil-selective chemokine receptor homologue.
    Kline JM; Heusinkveld LE; Taranto E; Martin CB; Tomasi AG; Hsu IJ; Cho K; Khillan JS; Murphy PM; Pontejo SM
    J Biol Chem; 2021; 296():100373. PubMed ID: 33548230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.
    Bochner BS; Bickel CA; Taylor ML; MacGlashan DW; Gray PW; Raport CJ; Godiska R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):527-32. PubMed ID: 10069890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Chemokine N-Terminal Modification on Biased Agonism at the Chemokine Receptor CCR1.
    Sanchez J; Lane JR; Canals M; Stone MJ
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation.
    Pease JE; Wang J; Ponath PD; Murphy PM
    J Biol Chem; 1998 Aug; 273(32):19972-6. PubMed ID: 9685332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine receptor CCR1 is constitutively active, which leads to G protein-independent, β-arrestin-mediated internalization.
    Gilliland CT; Salanga CL; Kawamura T; Trejo J; Handel TM
    J Biol Chem; 2013 Nov; 288(45):32194-32210. PubMed ID: 24056371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CC chemokine receptors 1 and 3 are differentially regulated by IL-5 during maturation of eosinophilic HL-60 cells.
    Tiffany HL; Alkhatib G; Combadiere C; Berger EA; Murphy PM
    J Immunol; 1998 Feb; 160(3):1385-92. PubMed ID: 9570558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of chemically synthesized derivatives of the human CC chemokine CCL15/HCC-2, a high affinity CCR1 ligand.
    Escher SE; Forssmann U; Frimpong-Boateng A; Adermann K; Vakili J; Sticht H; Detheux M
    J Pept Res; 2004 Jan; 63(1):36-47. PubMed ID: 14984572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.
    Tian Y; New DC; Yung LY; Allen RA; Slocombe PM; Twomey BM; Lee MMK; Wong YH
    Eur J Immunol; 2004 Mar; 34(3):785-795. PubMed ID: 14991608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.
    Sabroe I; Conroy DM; Gerard NP; Li Y; Collins PD; Post TW; Jose PJ; Williams TJ; Gerard CJ; Ponath PD
    J Immunol; 1998 Dec; 161(11):6139-47. PubMed ID: 9834099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in eosinophil chemokine responses: an investigation of CCR1 and CCR3 function, expression in atopy, and identification of a functional CCR1 promoter.
    Phillips RM; Stubbs VE; Henson MR; Williams TJ; Pease JE; Sabroe I
    J Immunol; 2003 Jun; 170(12):6190-201. PubMed ID: 12794150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells.
    Gouwy M; Struyf S; Leutenez L; Pörtner N; Sozzani S; Van Damme J
    Immunobiology; 2014 Mar; 219(3):218-29. PubMed ID: 24268109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.
    Sabroe I; Peck MJ; Van Keulen BJ; Jorritsma A; Simmons G; Clapham PR; Williams TJ; Pease JE
    J Biol Chem; 2000 Aug; 275(34):25985-92. PubMed ID: 10854442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration.
    Borchers MT; Ansay T; DeSalle R; Daugherty BL; Shen H; Metzger M; Lee NA; Lee JJ
    J Leukoc Biol; 2002 Jun; 71(6):1033-41. PubMed ID: 12050190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
    Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
    J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXC chemokine receptor 2 but not C-C chemokine receptor 1 expression is essential for neutrophil recruitment to the cornea in helminth-mediated keratitis (river blindness).
    Hall LR; Diaconu E; Patel R; Pearlman E
    J Immunol; 2001 Mar; 166(6):4035-41. PubMed ID: 11238651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
    Xanthou G; Duchesnes CE; Williams TJ; Pease JE
    Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential pattern of CCR1 internalization in human eosinophils: prolonged internalization by CCL5 in contrast to CCL3.
    Elsner J; Dulkys Y; Gupta S; Escher SE; Forssmann WG; Kapp A; Forssmann U
    Allergy; 2005 Nov; 60(11):1386-93. PubMed ID: 16197470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
    J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic activation of alternative CCR1 ligands in inflammation.
    Berahovich RD; Miao Z; Wang Y; Premack B; Howard MC; Schall TJ
    J Immunol; 2005 Jun; 174(11):7341-51. PubMed ID: 15905581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.